Rathnayaka M. K. Gunasingha, MD1, Patrick Benoit, DO1, and Matthew J. Bradley, MD2 1 Walter Reed National Military Medical Center, Bethesda, MD, USA 2 Uniformed Services University of the Health Sciences, Program Director General Surgery Residency, Walter Reed National Military Medical Center, Bethesda, MD, USA This patient has 3 minor Modified Duke Criteria – (1) intravenous drug use, (2) fever > 100.4°F, and (3) Osler’s nodes – that indicate possible endocarditis. Intravenous drug use is a risk factor for acquisition of infective endocarditis. The patient should receive a transesophageal echo (TEE) to evaluate his cardiac valves even though the transthoracic echocardiogram was negative as TEE is more sensitive for cardiac vegetations. Staphylococcus aureus is the most common organism that causes infective endocarditis, followed by Viridans group Streptococci, coagulase‐negative Staphylococci, Enterococcus species, and Streptococcus bovis. Antibiotics should be started immediately after drawing blood cultures and should be broad to include MRSA coverage. Answer B is the correct choice as it provides broad‐spectrum coverage as well as the TEE that is needed after a negative TTE in this patient whose presentation is suspicious for infective endocarditis. Answer A adequately covers for MRSA, but without a known causative organism, more broad‐spectrum antibiotics should be initiated. Answer C is incorrect as it is critical that in cases of suspected endocarditis and sepsis that antibiotics be administered immediately after presentation. Answer D does not adequately cover against MRSA and is therefore incorrect. Answer E does not adequately cover gram‐negative bacteria and is therefore inadequate as initial therapy for this patient. It is a strong recommendation to consult Infectious Disease to determine the optimal empirical antibiotic treatment. The fluctuance and induration at the patient’s antecubital fossa indicate an abscess and must be drained as part of the treatment. References for images: Answer: B Galindo R . Osler’s nodes on hand. https://commons.wikimedia.org/wiki/File:Osler_Nodules_Hand.jpg. Published 2010. Accessed July 26, 2021. Galindo R . Osler spots on foot. https://commons.wikimedia.org/wiki/File:Osler_Spots_foot.jpg. Published 2010. Accessed July 26, 2021 Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015; 132(15):1435–1486. doi:10.1161/CIR.0000000000000296 Vogkou CT, Vlachogiannis NI, Palaiodimos L, et al. The causative agents in infective endocarditis: a systematic review comprising 33,214 cases. Eur J Clin Microbiol Infect Dis. 2016; 35(8):1227–1245. doi:10.1007/s10096‐016‐2660‐6 Wang A, Gaca JG, Chu VH . Management considerations in infective endocarditis: a review. JAMA ‐ J Am Med Assoc. 2018; 320(1):72–83. doi:10.1001/jama.2018.75961. Miller SE, Maragakis LL . Central line‐associated bloodstream infection prevention. Curr Opin Infect Dis. 2012; 25(4):412–422. doi:10.1097/QCO.0b013e328355e4da Latif A, Halim MS, Pronovost PJ . Eliminating infections in the ICU: CLABSI. Curr Infect Dis Rep. 2015; 17(7). doi:10.1007/s11908‐015‐0491‐8 Noto MJ, Domenico HJ, Byrne DW, et al. Chlorhexidine bathing and health care‐associated infections: a randomized clinical trial. JAMA ‐ J Am Med Assoc. 2015; 313(4):369–378. doi:10.1001/jama.2014.18400 This patient has infected necrotizing pancreatitis based on the physiologic and laboratory changes and new findings on CT scan. Broad‐spectrum antibiotics should be started since the fluid collection appears to be infected on clinical exam and on CT scan. In general, there is no indication to start antibiotics in necrotizing pancreatitis unless there is a culture‐proven infection or a strong suspicion for infection (gas in collection, sepsis, and clinical deterioration). Prophylactic antibiotics should not be used for sterile necrosis. For infected pancreatic necrosis, a multicenter trial showed that a minimally invasive step‐up approach (percutaneous drainage followed by minimal invasive retroperitoneal necrosectomy if needed) reduced major complications and death when compared to open necrosectomy. Answer A is incorrect because patient has indications for the need of drainage of the fluid collection. Answer C is not optimal as necrosectomy is now suggested to be reserved for failure of a step approach method. Answer D is incorrect because antifungals are not yet indicated. Answer E is incorrect because there is evidence of infection. Answer: B Da Costa DW, Boerma D, Van Santvoort HC, et al. Staged multidisciplinary step‐up management for necrotizing pancreatitis. Br J Surg. 2014; 101(1). doi:10.1002/bjs.9346 Baron TH, DiMaio CJ, Wang AY, et al. American Gastroenterological Association Clinical Practice Update: Management of Pancreatic Necrosis. Gastroenterology. 2020; 158(1):67–75.e1. doi:10.1053/j.gastro.2019.07.064 van Santvoort HC, Besselink MG, Bakker OJ, et al. A step‐up approach or open necrosectomy for necrotizing pancreatitis. N Engl J Med. 2010; 362(16):1491–1502. doi:10.1056/nejmoa0908821 This patient has an enterocutaneous fistula, a very morbid complication after open surgery. Mortality is associated with sepsis, malnutrition, and fluid and electrolyte disturbances. It is important to control and treat sepsis as well as resuscitate the patient first. Effluent control and wound care are necessary to control output and prevent worsening and infection of any soft tissue wound. Nutrition is important for successful management of an EC fistula and can be a combination of enteral and parenteral, depending on nutritional needs and characteristics of the fistula. Oral toleration is not important initially and definitely not necessary. Characteristics of the fistula should be used to determine the appropriate nutrition source. Answer: E Evenson AR, Fischer JE . Current management of enterocutaneous fistula. J Gastrointest Surg. 2006; 10(3):455–464. doi:10.1016/j.gassur.2005.08.001 Rosenthal MD, Brown CJ, Loftus TJ, et al. Nutritional management and strategies for the enterocutaneous fistula. Curr Surg Reports. 2020; 8(6):1–10. doi:10.1007/s40137‐020‐00255‐5 Gribovskaja‐Rupp I, Melton GB . Enterocutaneous fistula: proven strategies and updates. Clin Colon Rectal Surg. 2016; 29(2):130–137. doi:10.1055/s‐0036‐1580732 This immunocompromised patient has signs and symptoms concerning bacterial meningitis. After blood cultures and broad‐spectrum antibiotics are started, dexamethasone should be given to adult patients. A trial that evaluated outcomes in adult patients with bacterial meningitis found that negative outcomes, including death, were significantly lower in the group that received dexamethasone versus placebo; the group with streptococcus meningitis saw the most benefit. Hence, current recommendations state starting dexamethasone for any patients with possible streptococcal meningitis and continuing it only if culture results confirm the diagnosis. CT scan of the head should be obtained before a lumbar puncture since this patient has physical exam findings of elevated intracranial pressure (ICP), is immunocompromised, and had a new onset seizure within 1 week of presentation (choice A, B). There is a small (~1%) chance of herniation in adults with elevated ICP. A lumbar puncture is eventually necessary to identify the exact organism causing meningitis but is not done immediately (choice D). Mannitol may eventually be used to lower ICP prior to performing lumbar puncture. Initial empiric antimicrobial treatment for patients with suspected bacterial meningitis includes vancomycin in combination with either ceftriaxone or cefotaxime. Answer: C a Ceftriaxone or cefotaxime. b Some experts would add rifampin if dexamethasone is also given. c In infants and children, vancomycin alone is reasonable unless Gram stains reveal the presence of gram‐negative bacilli. van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004; 351(18):1849–1859. doi:10.1056/nejmoa040845 Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004; 39(9):1267–1284. doi:10.1086/425368 chart citation: Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004; 39(9):1267–1284. doi:10.1086/425368
9
Infectious Disease
Modified duke criteria
Pathological criteria
Positive histology or culture from pathological material obtained at autopsy or cardiac surgery
Major criteria
Two positive blood cultures with typical organism
Persistent bacteremia
Positive serology for Coxiella
Positive echocardiogram
Minor criteria
Predisposing heart disease or IVDA
Fever > 38%
Immunological phenomena
Vascular phenomena
Microbiological evidence not fitting major criteria
Predisposing factor
Common bacterial pathogens
Antimicrobial therapy
Age
<1 month
Streptococcus agalactiae, Escherichia coli, Listeria monocytogenes, Klebsiella species
Ampicillin plus cefotaxime or ampicillin plus an aminoglycoside
1–23 months
Streptococcus pneumoniae, Neisseria meningitidis, S. agalactiae, Haemophilus influenzae, E. coli
Vancomycin plus a third‐generation cephalosporina,b
2–50 years
N. meningitidis, 5. pneumoniae
Vancomycin plus a third‐generation cephalosporina,b
>50 years
S. pneumoniae, N. meningitidis, L. monocytogenes, aerobic gram‐negative bacilli
Vancomycin plus ampicillin plus a third‐generation cephalosporina,b
Head trauma
Basilar skull fracture
S. pneumoniae, H. influenzae, group A β‐hemolytic streptococci
Vancomycin plus a third‐generation cephalosporina
Penetrating trauma
Staphylococcus aureus, coagulase‐negative staphylococci (especially Staphylococcus epidermidis), aerobic gram‐negative bacilli (including Pseudomonas aeruginosa)
Vancomycin plus cefepime, vancomycin plus ceftazidime, or vancomycin plus meropenem
Postneurosurgery
Aerobic gram‐negative bacilli (including P. aeruginosa), S. aureus, coagulase‐negative staphylococci (especially S. epidermidis)
Vancomycin plus cefepime, vancomycin plus ceftazidime, or vancomycin plus meropenem
CSF shunt
Coagulase‐negative staphylococci (especially S. epidermidis), S. aureus, aerobic gram‐negative bacilli (including P. aeruginosa), Propionibacterium acnes
Vancomycin plus cefepime,c vancomycin plus ceftazidime,c or vancomycin plus meropenemc